Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
229 studies found for:    Open Studies | "Colitis, Ulcerative"
Show Display Options
Rank Status Study
21 Not yet recruiting Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Flaxseed lignan-enriched complex (FLC);   Other: Placebo
22 Recruiting Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Apremilast;   Drug: Placebo
23 Recruiting Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: Adalimumab;   Other: Placebo
24 Recruiting Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: PTG-100;   Drug: Placebo group
25 Recruiting Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Colitis Ulcerative Exacerbation
Interventions: Drug: Azathioprine and Allopurinol;   Drug: Azathioprine
26 Recruiting Study of Cimzia for the Treatment of Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Cimzia
27 Recruiting Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: CP-690,550
28 Not yet recruiting Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: Fecal Microbiota Transplantation (FMT), OpenBiome;   Other: pretreatment antibiotics
29 Recruiting TD-1473 for Active Ulcerative Colitis (UC)
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Drug: TD-1473;   Drug: Placebo
30 Recruiting Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Other: colonoscopy
31 Not yet recruiting ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: ABX464;   Drug: Placebo oral capsule
32 Not yet recruiting Ulcerative Colitis Relapse Prevention by Prebiotics
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Synergy-1;   Dietary Supplement: Maltodextrin
33 Recruiting Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Linked Color Imaging;   Device: white light imaging
34 Recruiting Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Other: Probiotics in the form of cheese portion
35 Not yet recruiting Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
Condition: ULCERATIVE COLITIS
Interventions: Drug: VEDOLIZUMAB;   Drug: ADALIMUMAB
36 Recruiting Thermography in Surveillance of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Thermography;   Procedure: Colonoscopy
37 Recruiting Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: standard endoscopy;   Device: PillCamCOLON (C2)
38 Recruiting Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
39 Recruiting Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis
Condition: Moderate Active Ulcerative Colitis
Interventions: Drug: E6007;   Drug: Placebo
40 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Diseases
Interventions: Drug: Placebo IV;   Drug: Placebo SC;   Drug: Ustekinumab IV;   Drug: Ustekinumab SC

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.